Haploidentical stem cell transplantation for the treatment of leukemia: current status

被引:17
作者
Chang, Ying-Jun [1 ,2 ]
Wang, Yu [1 ,2 ]
Huang, Xiao-Jun [1 ,2 ,3 ]
机构
[1] Peking Univ, Peoples Hosp, Beijing 100044, Peoples R China
[2] Peking Univ, Inst Hematol, Beijing Key Lab Hematopoiet Stem Cell Transplanta, Beijing 100044, Peoples R China
[3] Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China
基金
国家高技术研究发展计划(863计划); 中国国家自然科学基金;
关键词
graft-versus-leukemia effects; haploidentical stem cell transplantation; leukemia; relapse; BONE-MARROW-TRANSPLANTATION; ACUTE MYELOID-LEUKEMIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; MINIMAL RESIDUAL DISEASE; UMBILICAL-CORD BLOOD; RISK ACUTE-LEUKEMIA; HLA-MISMATCHED/HAPLOIDENTICAL BLOOD; DONOR LYMPHOCYTE INFUSIONS; HEMATOLOGIC MALIGNANCIES; POSTTRANSPLANTATION CYCLOPHOSPHAMIDE;
D O I
10.1586/17474086.2014.954543
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Haploidentical stem cell transplantation (haplo-SCT), either with T-cell depletion or T-cell replete, has been a reliable source of stem cells for patients with high-risk leukemia who do not have matched donors because it provides comparable outcomes to human leukocyte antigen-matched sibling donor transplantation, unrelated donor transplantation and umbilical cord blood transplantation. Factors, such as the Hematopoietic Cell Transplantation-Specific Comorbidity Index, associated with transplant outcomes may help us design risk-stratification-directed intervention to improve the prognosis of leukemia patients. Preliminary results of novel protocols, including co-transplant of haploidentical allografts and cord blood, as well as human leukocyte antigen-mismatched stem cell microtransplantation, for leukemia have shown that these approaches are feasible. Several strategies for enhancing the graft-versus-leukemia effects significantly decreased the relapse rate after haplo-SCT. Future direction of research will focus on perfecting available haplo-SCT protocols and determining the optimal time of haplo-SCT for leukemia and 'fit' haploidentical transplant candidates.
引用
收藏
页码:635 / 647
页数:13
相关论文
共 78 条
[1]  
[Anonymous], BLOOD
[2]   Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype [J].
Aversa, F ;
Tabilio, A ;
Velardi, A ;
Cunningham, I ;
Terenzi, A ;
Falzetti, F ;
Ruggeri, L ;
Barbabietola, G ;
Aristei, C ;
Latini, P ;
Reisner, Y ;
Martelli, MF .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (17) :1186-1193
[3]   Full haplotype-mismatched hematopoietic stem-cell transplantation: A phase II study in patients with acute leukemia at high risk of relapse [J].
Aversa, F ;
Terenzi, A ;
Tabilio, A ;
Falzetti, F ;
Carotti, A ;
Ballanti, S ;
Felicini, R ;
Falcinelli, F ;
Velardi, A ;
Ruggeri, L ;
Aloisi, T ;
Saab, JP ;
Santucci, A ;
Perruccio, K ;
Martelli, MP ;
Mecucci, C ;
Reisner, Y ;
Martelli, MF .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (15) :3447-3454
[4]   Reversal of in situ T-cell exhaustion during effective human antileukemia responses to donor lymphocyte infusion [J].
Bachireddy, Pavan ;
Hainz, Ursula ;
Rooney, Michael ;
Pozdnyakova, Olga ;
Aldridge, Julie ;
Zhang, Wandi ;
Liao, Xiaoyun ;
Hodi, F. Stephen ;
O'Connell, Karyn ;
Haining, W. Nicholas ;
Goldstein, Natalie R. ;
Canning, Christine M. ;
Soiffer, Robert J. ;
Ritz, Jerome ;
Hacohen, Nir ;
Alyea, Edwin P., III ;
Kim, Haesook T. ;
Wu, Catherine J. .
BLOOD, 2014, 123 (09) :1412-1421
[5]   Selection of optimal alternative graft source: mismatched unrelated donor, umbilical cord blood, or haploidentical transplant [J].
Ballen, Karen K. ;
Koreth, John ;
Chen, Yi-Bin ;
Dey, Bimalangshu R. ;
Spitzer, Thomas R. .
BLOOD, 2012, 119 (09) :1972-1980
[6]   T-Cell-Replete HLA-Haploidentical Hematopoietic Transplantation for Hematologic Malignancies Using Post-Transplantation Cyclophosphamide Results in Outcomes Equivalent to Those of Contemporaneous HLA-Matched Related and Unrelated Donor Transplantation [J].
Bashey, Asad ;
Zhang, Xu ;
Sizemore, Connie A. ;
Manion, Karen ;
Brown, Stacey ;
Holland, H. Kent ;
Morris, Lawrence E. ;
Solomon, Scott R. .
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (10) :1310-1316
[7]   HLA-haploidentical stem cell transplantation after removal of αβ+ T and B cells in children with nonmalignant disorders [J].
Bertaina, Alice ;
Merli, Pietro ;
Rutella, Sergio ;
Pagliara, Daria ;
Bernardo, Maria Ester ;
Masetti, Riccardo ;
Pende, Daniela ;
Falco, Michela ;
Handgretinger, Rupert ;
Moretta, Francesca ;
Lucarelli, Barbarella ;
Brescia, Letizia P. ;
Li Pira, Giuseppina ;
Testi, Manuela ;
Cancrini, Caterina ;
Kabbara, Nabil ;
Carsetti, Rita ;
Finocchi, Andrea ;
Moretta, Alessandro ;
Moretta, Lorenzo ;
Locatelli, Franco .
BLOOD, 2014, 124 (05) :822-826
[8]   Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts [J].
Brunstein, Claudio G. ;
Fuchs, Ephraim J. ;
Carter, Shelly L. ;
Karanes, Chatchada ;
Costa, Luciano J. ;
Wu, Juan ;
Devine, Steven M. ;
Wingard, John R. ;
Aljitawi, Omar S. ;
Cutler, Corey S. ;
Jagasia, Madan H. ;
Ballen, Karen K. ;
Eapen, Mary ;
O'Donnell, Paul V. .
BLOOD, 2011, 118 (02) :282-288
[9]   Graft-versus-leukemia Effect of HLA-haploidentical Central-memory T-cells Expanded With Leukemic APCs and Modified With a Suicide Gene [J].
Casucci, Monica ;
Perna, Serena Kimi ;
Falcone, Laura ;
Camisa, Barbara ;
Magnani, Zulma ;
Bernardi, Massimo ;
Crotta, Alessandro ;
Tresoldi, Cristina ;
Fleischhauer, Katharina ;
Ponzoni, Maurilio ;
Gregori, Silvia ;
Cappio, Federico Caligaris ;
Ciceri, Fabio ;
Bordignon, Claudio ;
Cignetti, Alessandro ;
Bondanza, Attilio ;
Bonini, Chiara .
MOLECULAR THERAPY, 2013, 21 (02) :466-475
[10]   Haploidentical SCT: the mechanisms underlying the crossing of HLA barriers [J].
Chang, Y-J ;
Huang, X-J .
BONE MARROW TRANSPLANTATION, 2014, 49 (07) :873-879